Cipla Limited (BOM:500087)

Market Cap	1.24T
Revenue (ttm)	267.20B
Net Income (ttm)	49.90B
Shares Out	n/a
EPS (ttm)	61.74
PE Ratio	24.82
Forward PE	n/a
Dividend	13.00 (0.86%)
Ex-Dividend Date	Aug 2, 2024

Volume	20,692
Average Volume	43,175
Open	1,533.85
Previous Close	1,533.55
Day's Range	1,525.25 - 1,556.00
52-Week Range	1,310.05 - 1,702.00
Beta	n/a
RSI	62.92
Earnings Date	May 13, 2025

About Cipla

Cipla Limited, together with its subsidiaries, engages in the manufacture, development, sale, and distribution of pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer’s disease, hypertension, arrhythmia, lipid abnormaliti...

• Industry: Pharmaceutical Preparations
• Founded: 1935
• Employees: 27,764
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 500087

Financial Performance

In 2023, Cipla's revenue was 255.37 billion, an increase of 13.20% compared to the previous year's 225.59 billion. Earnings were 41.22 billion, an increase of 47.10%.